John J. Acton, III,Rajan Anand,Ashok Arasappan,Qun Dang,Iyassu Sebhat,Zhifa Pu,Takao Suzuki
申请号:
US14769159
公开号:
US20160002224A1
申请日:
2014.03.10
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.